Trials / NCT03418116
Argus II Retinal Prosthesis System - Better Vision RP Study
Withdrawn N/A Retinal implant
Why it stopped: Company Decision
- Sponsor
- Second Sight Medical Products
- Treatment
- Argus II Retinal Prosthesis
- Gene
- Not stated
- Conditions
- Retinitis Pigmentosa
- Ages
- 25 Years to no upper limit
- Enrollment
- Not stated participants
- Started
- 2018-11-01
- Main results expected
- 2021-11
- Results posted
- Not yet
- Record last updated
- 2019-06-25
What the study is testing
The study is conducted to evaluate the safety and benefit of the Argus II System in a selected patient population with advanced Retinitis Pigmentosa who have a measurable central residual visual field smaller than or equal to 5 degrees radius.
Where it runs
Germany (3)
- Augenklinik Städtisches Klinikum Karlsruhe, Karlsruhe, Baden-Wurttemberg
- University Medical Center Schleswig-Holstein, Department of Ophthalmology, Lübeck, Schleswig-Holstein
- RWTH University Eye Clinic, Aachen